The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.
 
Stefano Tamberi
No Relationships to Disclose
 
Elisa Grassi
No Relationships to Disclose
 
Jody Corbelli
No Relationships to Disclose
 
Giorgio Papiani
No Relationships to Disclose
 
Maria aurelia Barbera
No Relationships to Disclose
 
Chiara Zingaretti
No Relationships to Disclose
 
Chiara Carli Moretti
No Relationships to Disclose
 
Isacco Montroni
Speakers' Bureau - Olympus Medical Systems
 
Elisabetta Petracci
No Relationships to Disclose
 
Dora Caruso
No Relationships to Disclose
 
Sofia Nosseir
No Relationships to Disclose
 
Oriana Nanni
No Relationships to Disclose
 
Giovanni Luca Frassineti
No Relationships to Disclose
 
Maria Di Bartolomeo
Honoraria - Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly
Travel, Accommodations, Expenses - Roche; Sanofi
 
Marina Marzola
No Relationships to Disclose
 
Andrea Bonetti
No Relationships to Disclose
 
Fabio Gelsomino
No Relationships to Disclose
 
Carmine Pinto
No Relationships to Disclose
 
Davide Tassinari
No Relationships to Disclose
 
Giampaolo Ugolini
No Relationships to Disclose